Skip to main content

SomaLogic, Inc. (SLGC)

NASDAQ: SLGC · IEX Real-Time Price · USD
11.73 -0.35 (-2.90%)
Oct 27, 2021 11:54 AM EDT - Market open
Market Cap2.13B
Revenue (ttm)81.10M
Net Income (ttm)n/a
Shares Out73.62M
EPS (ttm)-0.53
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume194,857
Open12.04
Previous Close12.08
Day's Range11.52 - 12.06
52-Week Range9.83 - 14.39
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About SLGC

SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow-offrate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various types of biological samples for protein ...

IndustryHealth Information Services
Founded2000
Employees220
Stock ExchangeNASDAQ
Ticker SymbolSLGC
Full Company Profile

Financial Performance

In 2020, SomaLogic's revenue was $55.89 million, an increase of 73.64% compared to the previous year's $32.19 million. Losses were -$53.02 million, -6.99% less than in 2019.

Financial Statements

News

A new study using the SomaScan® Platform makes the connection between genes and proteins and their impact on human di...

BOULDER, Colo., Oct. 20, 2021 (GLOBE NEWSWIRE) -- In the largest proteogenomic study of its kind to date, an international research team led by scientists at the Berlin Institute of Health at Charité an...

1 week ago - GlobeNewsWire

SomaLogic Announces Upcoming Conference Participation and Analyst Meeting

NEW YORK and BOULDER, Colo., Sept. 22, 2021 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today is announcing upcoming conference participation in addition to it...

1 month ago - GlobeNewsWire

SomaLogic Announces Analyst and Investor Meeting on September 28

NEW YORK and BOULDER, Colo., Sept. 13, 2021 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, will host a virtual Analyst and Investor Meeting on Tuesday, September ...

1 month ago - GlobeNewsWire

SomaLogic announces strategic collaboration with UPMC to tailor clinical care through proteomics technology

BOULDER, Colo., Sept. 13, 2021 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a strategic collaboration with leading health system UPMC to e...

1 month ago - GlobeNewsWire

SomaLogic Reports First Half of 2021 Financial Results

NEW YORK and BOULDER, Colo., Sept. 08, 2021 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today reported financial results for the six months ended June 30, 2021.

1 month ago - GlobeNewsWire

SomaLogic to Present at Morgan Stanley 19th Annual Global Healthcare Conference

NEW YORK and BOULDER, Colo., Sept. 07, 2021 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the upcoming ...

1 month ago - GlobeNewsWire

SomaLogic Closes Business Combination and Will Begin Trading Under the Ticker “SLGC” on the Nasdaq Stock Exchange

NEW YORK and BOULDER, Colo., Sept. 01, 2021 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that it has completed its business combination with CM ...

1 month ago - GlobeNewsWire

SomaLogic expands leadership team with new positions to drive commercial success

NEW YORK and BOULDER, Colo., Aug. 31, 2021 (GLOBE NEWSWIRE) -- CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, a leader in AI data-driven proteomics technology, today announced the recent appointment...

1 month ago - GlobeNewsWire

SomaLogic Provides 2021 Financial Guidance Exceeding Initial Merger Combination Projections

NEW YORK & BOULDER, Colo.--(BUSINESS WIRE)--CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, Inc. (“SomaLogic” or the “Company”), a leader in AI-data driven proteomics technology, today announced that...

2 months ago - Business Wire

Should Investors Follow Private Equity into Life Sciences?

Reflecting what it considers the vast potential of life sciences companies, Bain Capital is making another huge bet on the industry. The Boston-based investment firm has raised $1.9 billion in a new fun...

2 months ago - GuruFocus

SomaLogic and Twist Bioscience Corporation announce partnership to discover novel therapeutic targets and antibodies

BOULDER, Colo. & SOUTH SAN FRANCISCO, Calif., Aug. 18, 2021 (GLOBE NEWSWIRE) -- CM Life Sciences II (Nasdaq: CMIIU) and SomaLogic, Inc., a leader in AI-data driven proteomics technology, and Twist Biosc...

Other symbols:TWST
2 months ago - GlobeNewsWire

SomaLogic Announces Registration Statement Declared Effective and Reports 176% Y/Y Second Quarter and 187% First Half...

NEW YORK & BOULDER, Colo., Aug. 16, 2021 (GLOBE NEWSWIRE) -- CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the registrat...

2 months ago - GlobeNewsWire

SomaLogic Announces Appointment of Shaun Blakeman as Chief Financial Officer

NEW YORK and BOULDER, Colo., Aug. 02, 2021 (GLOBE NEWSWIRE) -- CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, a leader in AI-data driven proteomics technology, today announced the appointment of Sha...

2 months ago - GlobeNewsWire

ARK Investment Leans Into Biotech and Telecom Holdings

Catherine Wood (Trades, Portfolio)'s ARK Investment has revealed additions to three biotechnology and telecommunications holdings according to GuruFocus' Real-Time Picks, a Premium feature.

Other symbols:CDXSIRDMSURF
3 months ago - GuruFocus

SomaLogic Customizable Protein Panels With Industry-Leading 7,000-Plex Assay Now Available

NEW YORK & BOULDER, Colo.--(BUSINESS WIRE)--CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, Inc., a global leader in proteomics technology, announced today that their new customizable protein panel p...

3 months ago - Business Wire

CM Life Sciences II Inc. Announces Separate Trading of its Shares of Class A Common Stock and Warrants, on or about A...

NEW YORK--(BUSINESS WIRE)--CM Life Sciences II Inc. (Nasdaq: CMIIU) (the “Company”) today announced that holders of the Company's units sold in its initial public offering may elect to separately trade ...

6 months ago - Business Wire

SomaLogic Latest to Take SPAC Route to Public Markets

SomaLogic is joining the growing number of companies going public via special purpose acquisition companies. The Boulder, Colorado-based health care company plans to merge with CM Life Sciences II Inc. ...

6 months ago - GuruFocus

Ark Funds, Illumina Invest In SomaLogic SPAC Deal: What Investors Should Know

A leader in the proteomics field is going public with a SPAC deal announced Monday. The SPAC Deal: SomaLogic announced a SPAC deal with CM Life Sciences II Inc (NASDAQ: CMIIU), valuing the company at $1...

6 months ago - Benzinga

SomaLogic, Leading AI-Data Driven Proteomics Platform for Advanced Research and Clinical Applications, to Combine wit...

NEW YORK & BOULDER, Colo.--(BUSINESS WIRE)--SomaLogic, a global leader in proteomics technology, powered by a proprietary platform, the largest clinical proteomic database and next generation artificial...

6 months ago - Business Wire

CM Life Sciences II Inc., Sponsored by Affiliates of Casdin Capital and Corvex Management, Announces Closing of $276 ...

NEW YORK--(BUSINESS WIRE)--CM Life Sciences II Inc. (the “Company”) announced today that it closed its initial public offering of 27,600,000 units at $10.00 per unit, including 3,600,000 units issued pu...

8 months ago - Business Wire

CM Life Sciences II Inc., Sponsored by Affiliates of Casdin Capital and Corvex Management, Announces Pricing of Upsiz...

CM Life Sciences II Inc. (the “Company”) announced today that it priced its initial public offering of 24,000,000 units at $10.00 per unit.

8 months ago - Business Wire

CM Life Sciences II IPO Registration Document (S-1)

CM Life Sciences II, Inc. has filed to go public with an IPO on the NASDAQ.

8 months ago - SEC